Gonzalo Sapisochin, MD, discusses the benefits of living donor liver transplantation in hepatocellular carcinoma.
Gonzalo Sapisochin, MD
Advertisement
Articles by Gonzalo Sapisochin, MD
Gonzalo Sapisochin, MD, discusses factors that help determine transplant eligibility in hepatocellular carcinoma.
Gonzalo Sapisochin, MD, assistant professor of surgery, University of Toronto, discusses neoadjuvant treatment for patients with hepatocellular carcinoma.
Advertisement
Latest Updated Articles
Dr. Sapisochin on Neoadjuvant Treatment for HCCPublished: September 20th 2018 | Updated:
Dr. Sapisochin on Determining Transplant Eligibility in HCCPublished: March 13th 2020 | Updated:
Dr. Sapisochin on the Benefits of Living Donor Transplant in HCCPublished: April 8th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
3
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
4
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
5